Although the TMA IHC analyses did not validate differences in RPRD1B expression levels between LRA and HRA, its predominant staining of neoplastic cells combined with the molecular profiling data suggest that RPRD1B should also be considered as a putative driver of colorectal tumor development. Here, RPRD1B is linked to colorectal neoplasm.